Skip to content

Aspen helps evacuate SA students stranded in the Ukraine

Aspen partners with South African Government to evacuate South African Student’s from the Ukraine conflict Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has partnered with the South African Department of International Relations and Cooperation (“DIRCO”) to assist in the emergency evacuation of South African students who have been studying at various Universities…

Read More

Aspen delivers double digit organic revenue grown in constant exchange rates

  Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced unaudited interim financial results for the six months ended 31 December 2021. SALIENT RESULTS Aspen reported the following salient results: Revenue from continuing operations increased by 4% (+10% in constant exchange rate (“CER”) to R19,4 billion…

Read More

Aspen presented with 2022 Economic Diplomacy (Global) Ubuntu Award

Cape Town, South Africa – JSE Limited-listed Aspen Pharmacare (APN), a global multinational specialty pharmaceutical company, has been presented with the South African Government and Department of International Relations and Cooperations’ (“DIRCO”) Ubuntu Award in the Economic Diplomacy (Global) category at its prestigious 6th annual awards ceremony hosted in Cape Town for this purpose. This…

Read More

Aspen confirms non-binding term sheet on manufacture and sale of an Aspen- branded COVID-19 vaccine throughout Africa

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to confirm that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA”), has confirmed a non-binding term sheet with Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica NV, two of the Janssen…

Read More

Aspen welcomes Kenyan President Uhuru Kenyatta to its Gqeberha manufacturing site

Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today welcomed Kenyan President, His Excellency President Uhuru Kenyatta, to its world class flagship manufacturing site in Gqeberha. President Kenyatta’s visit to Aspen forms part of a broader collaboration and deepening of ties between South Africa and Kenya to lessen Africa’s dependence on…

Read More

Minister Ebrahim Patel opens Aspen’s world class general anaesthetic manufacturing line

Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today hosted the Honorable Minister of Trade, Industry and Competition, Mr Ebrahim Patel who officially opened Aspen’s world class general anaesthetics production line at its Gqeberha-based flagship manufacturing site. This manufacturing capability will convert Aspen’s Gqeberha facility into one of the largest manufacturing…

Read More

Aspen increases revenue from continuing operations by 12% to R37,8 billion

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report the following salient financial results for the year ended 30 June 2021: Revenue from continuing operations increased by 12% to R37,8 billion (June 2020: R33,7 billion*); Normalised EBITDA from continuing operations increased by 3% to…

Read More

Stephen Saad discusses the J&J vaccine release with eNCA’s Sally Burdett

Aspen confirmed on 26 July 2021 that the first supplies to South Africa of the Johnson & Johnson COVID-19 vaccines, from the new API source located in Europe, were being released to Johnson & Johnson from its flagship Gqeberha-based manufacturing site. These vaccines will be further distributed throughout South Africa in line with the various…

Read More

Aspen confirms release of Covid-19 vaccines to Johnson & Johnson for supply to South Africa

Durban, South Africa – Aspen, a global multinational specialty pharmaceutical company, is pleased to confirm that the first supplies to South Africa of the Johnson & Johnson COVID-19 vaccines, from the new API source located in Europe, will be released to Johnson & Johnson from its flagship Gqeberha-based manufacturing site later today. These vaccines will…

Read More

Aspen statement on manufacture and supply of COVID-19 vaccines

Durban – Aspen, a global multinational specialty pharmaceutical company, was extremely disappointed to learn over the past weekend that specific batches of the Johnson & Johnson COVID-19 vaccine manufactured at our Gqeberha production site and designated for the South African market have to be destroyed due to the Good Manufacturing Practice risk of isolated material…

Read More
Scroll To Top